Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.10.2023 | Case report

Sunitinib

Thrombotic microangiopathy, cerebral infarction and hypertension: 2 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Sasaki K, et al. Sunitinib therapy for imatinib-resistant and/or intolerant gastrointestinal stromal tumors: comparison of safety and efficacy between standard and reduced dosage regimens. Japanese Journal of Clinical Oncology 53: 297-303, No. 4, Jan 2023. Available from: URL: http://doi.org/10.1093/jjco/hyac202 Sasaki K, et al. Sunitinib therapy for imatinib-resistant and/or intolerant gastrointestinal stromal tumors: comparison of safety and efficacy between standard and reduced dosage regimens. Japanese Journal of Clinical Oncology 53: 297-303, No. 4, Jan 2023. Available from: URL: http://​doi.​org/​10.​1093/​jjco/​hyac202
Metadaten
Titel
Sunitinib
Thrombotic microangiopathy, cerebral infarction and hypertension: 2 case reports
Publikationsdatum
01.10.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-48165-3

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Imatinib

Case report

Multiple drugs

Case report

Sertraline

Case report

Multiple drugs